0000711665-11-000029.txt : 20111209 0000711665-11-000029.hdr.sgml : 20111209 20111209171250 ACCESSION NUMBER: 0000711665-11-000029 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20111209 DATE AS OF CHANGE: 20111209 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DENBY PAUL J CENTRAL INDEX KEY: 0001136829 FILING VALUES: FORM TYPE: SC 13D/A SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHOTOMEDEX INC CENTRAL INDEX KEY: 0000711665 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 592858100 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-34804 FILM NUMBER: 111254090 BUSINESS ADDRESS: STREET 1: 147 KEYSTONE DRIVE CITY: MONTGOMERYVILLE STATE: PA ZIP: 18936 BUSINESS PHONE: 2156193600 MAIL ADDRESS: STREET 1: 147 KEYSTONE DRIVE CITY: MONTGOMERYVILLE STATE: PA ZIP: 18936 FORMER COMPANY: FORMER CONFORMED NAME: LASER PHOTONICS INC DATE OF NAME CHANGE: 19920703 SC 13D/A 1 form_13-da.htm DENBY SCHEDULE 13D AMENDMENT form_13-da.htm




 





 
Securities and Exchange Commission
 
Washington, D.C. 20549
 
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
(Amendment No. 2)
 
 

 
PHOTOMEDEX, INC.
(Name of Issuer)
 
 
Common Stock, par value $0.01 per share
 (Class of Securities)
 
 
719358301
(CUSIP Number)
 
 
Paul J. Denby
179 Milford Circle
Mooresville, NC  28117
(704) 662-3549
 

 
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 
 
October 31, 2011
(Date of Event which Requires Filing of this Statement)
 
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of §§240.13-d1(e), 240.13d1(f) or 240.13d-1(g), check the following box  o .
 
 
 
 
 
 
 
 
 
 

 
 

 


CUSIP No.  719358301*


 
  1
  NAMES OF REPORTING PERSON:
 
  Paul J. Denby
 
 
  2
  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
 
  (a)   o
  (b)   þ
 
  3
  SEC USE ONLY
 
 
 
 
  4
  SOURCE OF FUNDS:
 
  PF
 
  5
  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
 
  o
 
  6
  CITIZENSHIP OR PLACE OF ORGANIZATION:
 
  United States of America
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
 
 
 
  7
  SOLE VOTING POWER
 
 0
 
  8
  SHARED VOTING POWER
 
  239,465
 
  9
  SOLE DISPOSITIVE POWER
 
 0
 
  10
  SHARED DISPOSITIVE POWER
 
  239,465
 
 
  11
  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
 
  239,465
 
 
  12
  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
  o
 
  13
  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
 
  7.14%**
 
  14
  TYPE OF REPORTING PERSON:
 
  IN

* Former CUSIP No. was 719358202, new CUSIP No. reflects the 1-for-6 reverse stock split done on February 3, 2010.
** Based on 3,355,613 shares of Common Stock of the Company issued and outstanding as of November 14, 2011, as reported in the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 14, 2011.

 
 

 


 
            This Amendment No. 2 is being filed to update certain information in Items 4, 5, 6 and 7 of the original Schedule 13D, as amended (the “Schedule 13D”).  This Amendment No. 2 amends the Schedule 13D as specifically set forth herein; reference is made to the Schedule 13D for information on the matters not specifically addressed in this Amendment No. 2.  Except as amended hereby, the Schedule 13D remains in full force and effect.

All share amounts presented reflect a 1-for-6 reverse stock split, which was effected by PhotoMedex, Inc. (“Issuer”) on February 3, 2010.

Item 4 Purpose of Transaction
 
The disclosure in Item 4 is hereby amended to include the following:
    
The Issuer and Radiancy, Inc. (“Radiancy”) have entered into a definitive Amended and Restated Agreement and Plan of Merger providing for the acquisition of Radiancy by Issuer, which we refer to as the “merger agreement.” Subject to the terms and conditions of the merger agreement and in accordance with Delaware law, at the effective time of the merger, Radiancy will merge with PHMD Merger Sub, Inc., a wholly owned Delaware corporation and subsidiary of the Issuer. Radiancy will survive the merger as a majority-owned subsidiary of the Issuer. At the time of completion of the merger, outstanding shares of Radiancy common stock and preferred stock will be converted into the right to receive shares of common stock of Issuer (the “Shares”).  At the time of completion of the merger, the Issuer’s stockholders will receive warrants and/or options to purchase Shares.

The merger agreement has been attached hereto as Exhibit 2.1.  The foregoing description of the merger agreement does not purport to be complete and is qualified in its entirety by reference to the merger agreement.

Following the merger, the Issuer’s board of directors will consist of eight (8) directors. Three (3) of the director nominees have been identified by Issuer and five (5) of the director nominees have been identified by Radiancy. At the 2011 Annual Meeting of the Issuer’s stockholders, the stockholders will elect the directors of the Issuer to serve until the next annual meeting of the Issuer’s stockholders, which election shall be subject to the closing of the merger.

In connection with the merger, Issuer will also be seeking stockholder approval of changes to the Issuer’s articles of incorporation, including the following: (a) an increase in the number of authorized Shares to fifty million (50,000,000) and (b) authorization of five million (5,000,000) shares of preferred stock, par value $0.01 per share, which shall be designated as blank check preferred. The proposed Amended and Restated Articles of Incorporation of Issuer is attached hereto as Exhibit 3.1.  The foregoing description of the Amended and Restated Articles of Incorporation does not purport to be complete and is qualified in its entirety by reference to the Amended and Restated Articles of Incorporation of Issuer.

For more information regarding the merger and the proposed changes to the Issuer’s Amended and Restated Articles of Incorporation, see the Registration Statement on Form S-4 (File No. 333-176295), as amended from time to time, filed by the Issuer with the Securities and Exchange Commission (the “Commission”) and the Prospectus filed by the Issuer with the Commission on November 22, 2011, pursuant to rule 424(b) under the Securities Act of 1933, as amended.

Except as set forth above, Paul J. Denby (the “Reporting Person”) does not have any present plans or proposals that relate to or would result in: (a) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or of any of its subsidiaries; (d) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of such directors or to fill any existing vacancies on such board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure; (g) changes in the Issuer's charter, by-laws or instruments corresponding thereto or other actions that may impede the acquisition of control of the Issuer by any person; (h) causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration; or (j) any action similar to any of those enumerated above.

Item 5 Interest in Securities of the Issuer
 
The disclosure in Item 5 is hereby amended and restated to read in its entirety as follows:

(a)
The Reporting Person owns 239,465 Shares, which represent 7.14% of the issued and outstanding Shares.


 
 

 


 

(b)
The Reporting Person possesses the shared power to vote and dispose of his Shares described in Item 5(a) herein.
 
The power to vote and dispose of the Reporting Person’s Shares is shared with:
 
Name:  Radiancy, Inc.
State of Incorporation:  Delaware
Principal Business:  Developer and manufacturer of home-use and professional aesthetic and dermatological devices.
Address:  40 Ramland Road South, Suite 200, Orangeburg, New York 10962
To the best of the Reporting Person’s knowledge, Radiancy has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
To the best of the Reporting Person’s knowledge, Radiancy has not, during the last five years, been (i) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, or (ii) subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
 
(c)
On November 28, 2011, the Reporting Person made three purchases of Shares: 3,400 Shares at a price of $14.42 per share; 2,000 Shares at a price of $14.56 per share; and 200 Shares at a price of $14.75 per share. On November 29, 2011, the Reporting Person made two purchases of Shares: 1,300 Shares at a price of $14.75 per share and 1,100 Shares at a price of $15 per share. Each of the above listed transactions was conducted in the ordinary course of business on the open market for cash.
 
(d)
No person is known to have the right to receive, or the powers to direct the receipt of, dividends from, or the proceeds from the sale of, the Shares.
 
(e)
Not applicable.
 
Item 6 Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
 
The disclosure in Item 6 is hereby amended to include the following:
    
The Reporting Person entered into an Amended and Restated Shareholder Voting Support, Lock-Up and Confidentiality Agreement with Radiancy (the “Voting Support, Lock-Up and Confidentiality Agreement”) which is attached hereto as Exhibit 9.1.  In addition, other investors representing approximately 48% of the currently issued and outstanding Shares have each, individually, entered into the Voting Support, Lock-Up and Confidentiality Agreement with Radiancy.  The following description of the Voting Support, Lock-Up and Confidentiality Agreement does not purport to be complete and is qualified in its entirety by reference to the Voting Support, Lock-Up and Confidentiality Agreement.

Pursuant to the Voting Support, Lock-Up and Confidentiality Agreement, the Reporting Person has agreed to appear in person or by proxy at the Issuer’s stockholder meeting called for purposes of adopting the merger agreement and approving the merger and the transactions contemplated thereby, and to vote: (i) in favor of the adoption of the merger agreement and the approval of the merger and the transactions contemplated thereby; (ii) against any proposal made in opposition to, or in competition with, adoption of the merger agreement and approval of the merger and the transactions contemplated thereby; and (iii) against any other action that is intended, or would reasonably be expected to, impede, interfere with, delay, postpone, discourage or adversely affect the adoption of the merger agreement and approval of the merger and the transactions contemplated thereby; at any such meeting of stockholders or at any adjournment thereof, or in any other circumstances upon which a vote, consent or other approval with respect to the merger, the merger agreement or the transactions contemplated thereby is sought by the Issuer.

Pursuant to the Voting Support, Lock-Up and Confidentiality Agreement, the Reporting Person has agreed, subject to certain exceptions, that he will not directly or indirectly, prior to the termination of such agreement: (i) transfer, assign, sell, gift-over, pledge, encumber, hypothecate, exchange or otherwise dispose (whether by sale, liquidation, dissolution, dividend or distribution), or offer or solicit to do any of the foregoing, of any or all of the equity securities and/or any debt or similar securities that are convertible into equity securities of Issuer held by him, including any additional equity securities and/or any debt or similar securities that are convertible into equity securities of Issuer, which such stockholder may subsequently acquire, including all additional equity securities which may be issued to such stockholder upon the exercise of any options, warrants or other securities convertible into or exchangeable for securities of Issuer (all such securities of such stockholder, “Subject Securities”) or any right or interest therein, or consent to any of the foregoing (any such action, a “Transfer”), (ii) enter or offer to enter into any derivative arrangement with respect to, or create or suffer to exist any liens or encumbrances with respect to, any or all of the Subject Securities or any right or interest therein, in either case that would reasonably be expected to prevent or delay such stockholder’s compliance with his obligations under such agreement; (iii) enter or offer to enter into any contract, option or other agreement, arrangement or understanding with respect to any Transfer; (iv) grant any proxy, power-of-attorney or other authorization or consent with respect to any Subject Securities with respect to any matter that is, or that could be exercised in a manner, inconsistent with the transactions contemplated by the merger agreement or the provisions thereof; (v) deposit any Subject Securities into a voting trust, or enter into a voting agreement or arrangement with respect to any Subject Securities; or (vi) enter or offer to enter into any contract or agreement that would be breached by, or take any other action that would reasonably be expected to prevent or delay such stockholder’s compliance with its obligations under such agreement.

 
 

 



Item 7 Material to Be Filed as Exhibits

2.1
--
Amended and Restated Agreement and Plan of Merger, dated as of October 31, 2011, by and among Radiancy, Inc., PhotoMedex, Inc. and PHMD Merger Sub, Inc. (Incorporated by reference to Exhibit 2.1 to the Issuer’s Form S-4/A, filed with the Commission on November 2, 2011)
3.1
--
Proposed Amended and Restated Articles of Incorporation of PhotoMedex, to be voted upon by the shareholders of the Issuer at its annual meeting of stockholders scheduled to be held on December 12, 2011.
9.1
--
Amended and Restated Shareholder Voting Support, Lock-Up and Confidentiality Agreement, dated as of October 31, 2011, by and among Radiancy, Inc., and the parties signatory thereto. (Incorporated by reference to Exhibit 9.2 to the Issuer’s Form S-4/A, filed with the Commission on November 2, 2011)

 
SIGNATURE
 
After reasonable inquiry, and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Dated this 8th day of December, 2011
 
 
/s/ Paul J. Denby                      
 
Paul J. Denby
 
 
 
 
 



EX-3.1 2 ex_3-1.htm PROPOSED/AMENDED ARTICLES OF INC PHMD ex_3-1.htm


EXHIBIT 3.1

AMENDED AND RESTATED
 
ARTICLES OF INCORPORATION
 
OF
 
PHOTOMEDEX, INC.
 
(A NEVADA CORPORATION)
 
 
 
PhotoMedex, Inc. (the “Corporation”) a corporation organized and existing under the laws of the State of Nevada, pursuant to the provisions of Nevada Revised Statutes (“NRS”) Section 78.030 hereby adopts the following Articles of Incorporation:
 
FIRST: The name of the corporation is PhotoMedex, Inc..
 
SECOND: The address of the registered office of the Corporation in the State of Nevada shall be at Jolley Urga Wirth Woodbury & Standish, 3800 Howard Hughes Parkway, Sixteenth Floor, Las Vegas, Nevada 89169.  The name and address of the Corporation’s registered agent in the State of Nevada is Jolley Urga Wirth Woodbury & Standish.
 
THIRD: The purpose of the Corporation is to engage in any lawful act or activity for which corporations may now or hereafter be organized under the Nevada Private Corporations Law of the State of Nevada.
 
FOURTH: The total number of shares of stock which the Corporation shall have authority to issue is Fifty Million (50,000,000) shares of Common Stock, par value $0.01 per share (the “Common Stock”) and Five Million (5,000,000) shares of Preferred Stock, par value $0.01 per share (the “Preferred Stock”) which shall be designated as blank check preferred.
 
FIFTH: The Board of Directors shall have the authority to authorize the issuance from time to time of one or more classes of Preferred Stock with one or more series within any class thereof, with such voting powers, full or limited, or without voting powers and with such designations, preferences and relative, participating, optional or special rights and qualifications, limitations or restrictions thereon as shall be set forth in the resolution or resolutions adopted by the Board of Directors providing for the issuance of such preferred shares.
 
SIXTH: In furtherance and not in limitation of the powers conferred by statute, the Board of Directors is expressly authorized to adopt, repeal, rescind, alter or amend in any respect the Bylaws of the Corporation (the “Bylaws”).
 
SEVENTH: The business and affairs of the Corporation shall be managed by and under the direction of the Board of Directors.  The exact number of directors of the Corporation shall be determined from time to time by a Bylaw or Amendment thereto provided that the number of directors shall not be reduced to less than three (3), except that there need be only as many directors as there are stockholders in the event that the outstanding shares are held of record by fewer than three (3) stockholders.  Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall so provide.
 

 
 
 

 


As of the date of the filing of this Amended and Restated Certificate of Incorporation, the Board of Directors shall consist of [●] directors and the directors shall be [●], all with an address of [●].
 
EIGHTH: Each director shall serve until his successor is elected and qualified or until his death, resignation or removal; and no decrease in the authorized number of directors shall shorten the term of any incumbent director.
 
NINTH: Newly created directorships resulting from any increase in the number of directors, or any vacancies on the Board of Directors resulting from death, resignation, removal or other causes, shall be filled solely by the affirmative vote of a majority of the remaining directors then in office, even though less than a quorum of the Board of Directors.  Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the class of directors in which the new directorship was created or the vacancy occurred and until such director’s successor shall have been elected and qualified or until such director’s death, resignation or removal, whichever first occurs.
 
TENTH: Meetings of stockholders of the Corporation may be held within or without the State of Nevada, as the Bylaws may provide.  The books of the Corporation may be kept (subject to any provision of applicable law) outside the State of Nevada at such place or places as may be designated from time to time by the Board of Directors or in the Bylaws.
 
ELEVENTH: The Corporation reserves the right to adopt, repeal, rescind, alter or amend in any respect any provision contained in these Articles of Incorporation in the manner now or hereafter prescribed by applicable law, and all rights conferred on stockholders herein are granted subject to this reservation.
 
TWELFTH: The following paragraphs shall apply with respect to liability and indemnification of officers and directors:
 
A. To the fullest extent permitted by law, as the same exist or as may hereafter be amended, a director or officer of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for any action or failure to act as a director or officer, save and except for acts or omissions which involve intentional misconduct, fraud or a knowing violation of law. Any repeal or modification of this article shall be prospective only and shall not adversely affect any limitation on the personal liability of a director or officer of the Corporation for acts or omissions prior to such repeal or modification. The limitation on liability provided in this article shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors, and administrators of such person.
 
B. The Corporation, to the fullest extent permitted by Nevada law, as amended from time to time, shall indemnify any director or officer of the Corporation and may, in the discretion of the Board, indemnify any other person or persons whom it may indemnify pursuant thereto, who was or is a party, or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, including an action by or in the right of the Corporation, by reason of the fact that he or she is or was a director, officer, employee or agent of the Corporation, or is or was serving
 

 
2

 

 
 
at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, (including attorneys’ fees, judgments, fines and amounts paid in settlement) actually and reasonably incurred by him or her in connection with the action, suit or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.  Such expenses incurred in defending such action, suit or proceeding shall be paid by the Corporation in advance of the final disposition, upon receipt of an undertaking on behalf of the person to repay such amounts if it is determined that he or she is not entitled to be indemnified by the Corporation as authorized hereby, provided that the Board of Directors shall not have determined that such person acted in bad faith and in a manner that such person did not believe to be in, or not opposed to, the best interest of the Corporation, or with respect to any criminal proceeding, that such person believed or had reasonable cause to believe his conduct was unlawful. Such right of indemnification shall be a contract right which may be enforced in any manner enforced in any manner desired by such person. Such right of indemnification shall not be exclusive of any other right which such directors, officers or representatives may have or hereafter acquire, and, without limiting the generality of such statement, they shall be entitled to their respective rights of indemnification under any bylaw, agreement, vote of stockholders, provision of law, or otherwise, as well as the rights under this Article. The indemnification provided in this Article shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors, and administrators of such person.
 
THIRTEENTH: No contract or other transaction of the Corporation with any other person, firm or corporation, or in which this corporation is interested, shall be affected or invalidated by: (a) the fact that any one or more of the directors or officers of the Corporation is interested in or is a director or officer of such other firm or corporation; (b) the fact that any director or officer of the Corporation, individually or jointly with others, may be a party to or may be interested in any such contract or transaction; or (c) the fact of the common directorship, office or financial interest is not known to the director or officer at the time the transaction is brought before the board of directors of the corporation for action, so long as, in any of situations described above, the contract or transaction is authorized, approved or ratified at a meeting of the Board of Directors by sufficient vote thereon by directors not interested therein, to which such fact of relationship or interest has been disclosed, or the contract or transaction has been approved or ratified by vote or written consent of the stockholders entitled to vote, to whom such fact of relationship or interest has been disclosed.
 
FOURTEENTH: The name and address of the incorporator is:  Judi Herring, 3800 Howard Hughes Parkway, Suite 1600, Las Vegas, NV 89169.  All powers, duties and responsibilities of the incorporator have ceased upon the original filing of the Articles of Incorporation by the Secretary of the State of Nevada.
 
Dated this ___ day of _________, 2011.
 
 
 
   
 

 
3



 
GRAPHIC 3 qlogo.jpg PHMD LOGO begin 644 qlogo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`! M````/@```!L!!0`!````1@```"@!`P`!`````@`!`3$!`@`0````3@`````` M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`0$! M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H* M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`$4! M5P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_ MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($ M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$` M`A$#$0`_`/L+_@I(W_!77]@?X$:M^T_\.OVX-.\:>'M"N+<:SI>M^#;:"Z@A MFF2%94,8VR`/(@*X4@$GG!KQG_@EW^V)_P`%@O\`@JEXF\46>A_M7>'O!FB^ M$(+5M6U-/!\,\KR7!E\J../(&2(9"6)P-HX.:^XO^"\C?\:H/BX"/^8;8?\` MIRM:^*O^#1[_`)`OQX_Z^O#?_H.IU]-0G&625*\H1YT[)V7EY6ZGQ&*IU(<2 M4L+&I)0E%MKF>Z3ZWOT1]#?M'?"3_@M_^SC\/[WXN_!#]L/0/BHVBV[W6H>$ M=8\%0VMQ,-0U[7M>^(BO?ZKJETTTTQ6SBZLQS@9.!T`X'%>\_\%Z,M_P`$H?BH M2.38V!(_[?[>OGO_`(-4]CR)+2*^C:53[H# MD?E6KD8SFO`<7'<^MC*,M@``X%%&1ZUFZYXP\*>&%1O$?B?3]/\`,^Y]MO8X MMWTWD9H2;V"4HQ5V:5%5[#4M.U:V6_TJ_AN87&4EMY0Z-]"#@U-)(D2&21@J MJ,EB<`"E9W&I1:O<-Q`!HZ<9^G%?DU_P6C_X+E^'?`9C_9._8W^(22Z_O96=[+J_4\JEG.`K8F=&,U[ MMKNZM=]$?25%4=`UW1_%.AV?B;P]J4-[8:C:QW5C=V[AHYX9%#)(I'564@@^ MAIVKZ]H?A^U-]KNLVME"IP9KRX6)/S8@5QV=['JUVSOH0<>;9722KGZJ2*NGD8S2::",HR5T>`?M:_`S]M7XC:[%XI_95_:^M_ M`AMM-$0T'5/"L-]9W,X9F\UW)$B[@57C(&W.*_'6X_X+I_\`!3;X!_MBP?#' M]I7XDZ1<:?X1\:KIWC+2M-TB!(;F"*?9-MD"[MI7+!A@XQP.E?T#,Q"$D\X/ M-?S5_P#!0+]F&Y^('P$\2_\`!1WP];/,NI_'_P`3:+KDB\@6QNG-G*?;Y6C) MZ99!WKZ3(GAZ_-2KQ36B3LKW=^I\=Q.L5A5"MAIR4M6U=V:5NE_,_I)\/:_I M'BK0+'Q/H-XMQ9:A:1W-I.AXDB=0RL/J"*N@@]%KX5_X-[?VM/\`AIS_`()\ MZ1X:UW4O.\0?#J\;P]J@=\N\"*'M93WPT3!,]VB>ONH#`R3T[UX6*H2PV(G2 MENG8^GP.*CC<'"M':23_`,_N9\6_\%R/^"@/BG]@G]D:/7?A3KL=EXX\5:NF MG^&I7A60PJ@\RXGV,""%0`9(QF1?6OA__@EM^W)_P6(_X*:?$#6/A[X<_:=\ M/>&])\.V$=SK?B"Z\)0SS@.VU$B0;0SG!Y.`,9YZ5WO_``4?TL?MX?$_]I+X MIW"_:_!G[.WPOG\-^&LG=%/X@NRLMY,O;='&@0D?],C7F'_!IKJ[)\9_BUHF M>'\-6$P'N+AA_6OI*%"A0R6I/D3J1LVVD[7M;\&CX[%8O$XKB.G3YW&G*Z23 M:O;1OYM'[)?`KP1\1OA[\-[+PO\`%7XLW/C76X2[7?B"ZTZ*U:?]5]0U/3M)M'O\`4KZ&WAC&9)KB4(BCW)X%?+-N^Q2?V1_:^_[+]HQ\GF[/FV9ZXYK7#` M#):LF7QOX+BU8:#)XPTQ;XG`LFOXQ+GTV;L_I3BG>Z0IRC:S=C^?'_@IY^UG M_P`%./$O[8$'[$_[7'Q*L+"Q'B#2TF\/^")&BTN_@N)(GBX\]*_H!0`JI!Z"O=SCE^ MJ89QBE>+>BLKNQ\MPZZCQV+4Y.5I))MW=E>PZBJ^H:C8:5:/?:E>PV\,:Y>6 M>4(JCW)X%5]$\4>&O$L+7'ASQ#8WZ(<.]E=I*%/H2I.*\+EE:Y]5SQO8T**P MG^)/P\CNY+"7QSI"3PN4EA?4H@R,.H(+<&B7XF_#>"5;>7Q]HH=V"HG]IQ9) M/08W468[HW:*R=6\;>#O#U\FF:_XJTZRN)$WI#=WJ1LRYQD!B.,@U%'\0_`$ MUY#IMOXWTF2XN'"001ZC&SR,>@`#9)I6871MT444#"BBB@`HHHH`^0?^"\F? M^'3_`,7,G_F'6'_IRM:_.S_@V!_:E_9S_9[_`.%Q>'OCM\;O#'@ZYUZ30YM' M_P"$FUF&Q2[6`7PE"/,RJ64S1_+G/S9QP:_1/_@O)G_AT_\`%S(_YAUA_P"G M*UKX!_X-:/@C\'/C)H7QNC^+?PJ\.^)Q8W'AX67]O:+!=FWWKJ._RS*K%-VU M,=!BO/IYA3PF&E3PT6G+>3>MNR2/7JY16QV+A6QK_E%+\52.GV*PX_[B%O7YM?\$.OV5/VL?VQ?V7?%GPE\&?M(7/P MS^%@\6-)XDN_#*D:SK%TUO&/LPDR/*MP@!."-Q;!R!BOTF_X+U@C_@E+\51_ MTYV'/_;_`&]?//\`P:H_\F9>.>/^:@-_Z20UWX6M*AD$YQM=2ZJ_;N>7CZ%/ M$<4TJSM??30^<_^"F__!"G7?V%_@=>?M+-0;PO-%/K=MJ% MR8KJ"-G"_:8IHF!RKLN0>><@U]S?\$`_V[OB9^VW^R!=CXSZO)JGB?P1K`TF M^UF8?O;^$Q"2&20_Q2;3M9NK$9/))KU7_@L:B-_P3'^,@90?^*2?K_UVCKXN M_P"#37_DWWXKY_Z'*T_])!2G5GCLCG4K:RA))/K9V_S"GAZ>6<2PHX?2$XMN M-W:ZOKKZ'IO_``7@_P""O7B/]A7P_IW[/G[/E]"GQ'\36!NKC4F19#H=B6*) M(%.09I&5]@(.`I8CE:;%,07CW1RLVZ*0*ZY/SHP&&^:OT?\`V%_VM_AI M_P`%'?V0]+^,FDZ7&+;7K.;3?%&A2ON-G=`&.XMGQSM(;Y")GZ"E4A'%Y+]8E\<)6OU:TW^\=*I+`<1?4X?PY MQO;HGY=D['QC_P`%Q/V8/@)^SG_P4:T'X4?!/X9Z?X=\/7NDZ7+=Z38&3RI' MEF*R,=S$Y8=<&OUTTK_@A+_P2CUS0;&]OOV1--6::SB>1X/$6J1Y8J"3A;H# MK[5^87_!Q3*[?\%:/#L)/":+HFW\9S7[Z^$N?"^F`_\`/A#W_P!@5MF>)Q%/ M+\,XS:;CK9O7;$JYMC(SIII25DTFEZ=CY._P""H7[>?@/_`().?L>Z M9;_#?P_:-KDEG%H/PY\.RR,T4*01*@D?)+-%#&%ZG+':,\DU\M_\$L/^"?&N M_P#!1?X?']O+_@IQXU\1?$&X\3W4C>$/"VH:U<06%K:*Q7SO*A=`%9@=D:X4 M*N2&+<>%_P#!U[K6O3?M+_#70;AW&G0>#IYK5TW2 M-)_8+^$MCH>T6J>!=/\`+V#CF%2?U)K&I'ZCE%.I#XYMW?6W9/H;TI?VEG]2 MA57[NDE:/1MVU:ZGPU_P5'_X)C0_L5?!^_\`VYO^"9GBCQ'\-]?\#HM_X@T3 M0]>N9+2]L58>;)Y4KN#L'S,AS&R!LKQS]"_\$8/^"GT/_!1[X#7DWC2&UL_B M!X1:&W\56EJ-LOBO1M/:0V-[\,KIK^,'YJEUMV;ZCQ$GE>?T84=(54TX]+KJET^1^]OCOQ': M>#?!&L^+;Y]L.EZ5<7DS$]%BB9R?R6OSF_X)O?LM:=^U=_P08N_@WXHM5DG\ M>V^L7UO(ZY*7IN6D@E&>ZS1H0?:OL3_@H_XU/P\_8)^,'BP2['@^'>JQQ-G& M));5XD_\><5QG_!&?PU_PB?_``3#^#ND.@!;PJ+@C'7S9I)<_DXK@HRE1P3J M1WYE;Y)L]7%4X8G,HT9*ZY)7^;2_0_(;_@W=_:,UC]E+_@H5J7[-OQ`G>PL_ M&Z2Z+?VD[%5BU2V=C"2#_%D2)G_;K]O_`-MW]HO2?V3?V4_''Q^U212^@:'* M^G0GK<7LF(K:%?4O,\:_C[5^&'_!>WX!>)/V(_\`@II:_M"_#*-K&S\72V_B MK0KJ%,+!J4,H%Q'QW$J))C^[.!7W]\7/C_X?_P""KOQ7_9D_9W\"RB?PMJ^G M6WQ,^)]NC;E@M[5<16,N.YNPT9'X_P`->WF-"&+JTL9'X9*\ODKO_(^;R?%5 M3[L<*_[3N54>YK\D/\`@GWH_P`3O^"ZO[1O MB[]H3]N'XD:FOPM\'W<<.C?#VPUN2RT]YY,LD&V-U+!$&YY,[V+*-P&`/I?_ M`(.?M8UW3/\`@FQ;V6DR2"WO_B+I<&IA,X,`ANI`#[>;'%^.*\&_X-[?^"?? M['/[5'[$NL^/?CC\)K7Q%KEM\0+VRDN)KZ>,QPK:VCHFV-U&/G8YQGYJQP-* MEA\IGB6[2;LFE=I>6O4Z,RKU\7G]/!JSC%:5Q(R[PY4`J41] MR\9'VC_P2H_;LMO^"A7['^D?'*]L8;/7;6[ETGQ59P']W%J$*HSE?1722.0# ML),=JPI_^"(7_!+RY;S+G]E#1I&_O27=R3^LE=SI_P"S1\%_V(_V4/B#X9_9 M0^'-MX6MFT/5-76ST]W/F7_V(J)JZK169^:W[8?_``4?_:2_X*8?M_6/_!-?]B+X MFWOA'P4VOS:9K_BO1)VCN-0BM]QO+CSD(9;=5CD"*I'FG;DD,!7VUX&_X(4? M\$YO"G@M/#>M_"/4/$&IF$"Z\4:MXGOSJ$TN.90\0%4#US7Y7_`/!L M79Z?J?\`P4JU2_U9E:Z@\`:I+;;QSYC7%LK$>^UF_,U_0KR>O.:Z@^5))NVC;[MG%P_".:T9XO$I2E*32OJDET2>Q_-E_P4'^`6N_LS_P#!8?PM M\(M3^*FN^+['3_$/AI_#^I>);UKF]@T][B)HK625N9/*)=%)_A"].@_H/_:< M_:#\#?LJ_`/Q-^T!\1;ORM)\,:4]W.H(#3..(XE]6=RJ`>K"OP]_X+<_\IV_ M"?\`U]>$?_1Z5]W?\'.6LZ]IG_!,[[#I+R"WU#Q_I5OJFSH8`EQ*`WMYL<7X M@5TXR'UQX*,W\2U_"YPY;5^H1S"I37PMV^5['R_^P)8_%'_@NY^TKXN^/'[; M'Q)U.#X4>#;F./2?A[I^MR65A)-+N:.#$;*6VHNZ23.]BRC<`0!ZG_P5?_8W M^`7[`/P#/[;7_!/OXCR_"SQOX/U2R!TW1/%DKV^N037"0O"UO-,XD8"3>5`* MLBON4]1PO_!O%_P3_P#V//VJ_P!B[Q'XZ^.WPHM?$.N6OQ%O+%9YKZ>,QVZV M5D\:[8W48W22')'>ONN?_@B#_P`$OKIO,NOV4=&D;U>[N2?UDJ<7BL/AL?R7 M:A!VY4E9KJM];][&F7X'%XW*54Y4YS3?.V[IO9K32W:YYW^PMXY^%W_!6?\` M8FM_CF/!^F^'_B!:7$/A= M^T1_PB7QS\*6K%9VLMVIQ!TLKH,-DF&XP2,;NV01Q7V!^S7^R;^SY^R#X0O/ M`7[.?PTL_"^D:AJ)OKVTLG=A-<%$C,A+L3G:BC\*\;_X**?"KPQ=QZ;\0=(G M6/Q#/)]G-A"A:2^B52V\!>)5JT9UY>S346]%V/J<-2KTL+!5FG- M)7:V;[G4?MD:#X>^+6N:/\&?"GANRO\`Q=J+I*^IF(%]*L5;+.[CD*V3A3P< MGU%=Q\(/V4_A#\)-/LY;3PO;7^K6V'?6;^$23>:/XDW9$>#TVX_&O)/^"=7C M_P`(ZW)K6E:S/))XOGV/)>WDN][JT0!51">0$[K[@_3ZHV`G)KGFW'W3J@HR M]X6BN:\?^,1X&EM+V_;6[ M9;?3Y#'>7#2@1Q.`"5+=,@$9';-39FET:=%4-#URU\0:>FJZ?'+Y$O,$DJ%? M-7LP!YP>V<9ZTS4?%GA_2KI+"\U.+[2_W+6,[Y6^B+DTAFE14=M,9XEE,3IN M&0L@P?Q':B@#\P?^"[?_``4^_8P\3?L'^,_V=?A=\;]%\6^+/%;V5K:67A^[ M%U'`D=Y#-)+)*F4`"1,``22Q''>OD?\`X-M/V]/V:_V0_%OQ*^'_`.T1\0+? MPPGC1=*FTC5=05A;>9:_:E:)W`.PD7(()X^4\BOV6T[]G/P3HW2S#"4\OE MA.1\LG=NZO?3R\CYBME./K9K#'>T2E%62L[6\]?,[[X>?$?P'\6?"=IX^^&7 MC#3=?T6_5FLM5TF]2>"8!BIVNA(.""#Z$$5N'`.<8KA?">B^,O`.A0>%O`_P MF\)Z/IEMN^S:=I=^;>"+)+';'';A5R22<#DDFM+^UOB^3@^"]#^G]N2?_&*\ M5IUNQ M)=P#SX;@O*BY,:^6H8;L9W+C.:^>O^#8/]L+]GGX<_"GQ;^SC\1_B9IF@>)] M4\71WNAV>JW(A&HI)#'$%B9L*SATQLSDY&`:_475_A%9:_XGG\::]^S=\/+W M6;G;]IU:[2.2YEVJ%7=*UJ7;"@`9/``%0/\``_09=5M] M-!$987!R&1_LF58'H0:( M@=PC'EO\YPN5(S7P_P#\&Q7[9?[._P`#M`^('P4^,7Q0TGPUJVOZ[9WNBG6+ MH01WF(O*:-9&^7>"!P2"=PQFOUO\5?#`>/--OV>/`&L:G!!Y,&HZH4N M)XX@2P19)+4L%R2<`XR3ZU3U#X%^'=7FAGU/]ESX9W#P.'A:XMX7,;`Y#`FT MX(/.14T<;0IY?+#.+?,[MW6^G2WD&(RO%5LVAC5-+E5DK/9[W=S\U?\`@XW_ M`."97Q/\>>+[']OW]G7P]=:I=V&FQ6_C73=-C+W""WY@OXU4$L%3".!T$:-Z MU]J?\$UO^"H7[//[9O[.GA[7M0^)>B:/XTL-+AM_%OAW4M1CMY[>[C0+)(B2 M,"\3,"RL,X!P<$5]#G4OBX%V'P5H>,=/[+?B M7^P[\,;_`%.XD,ES?Q7$EM+.YZM(T$*%V/_\`%%W2;[IK9_(^(?\`@X"_;G\/_M/:'X?_`."59S(0[$'""+D\\?:/\`P1X_8&F_X)\_L>Z9 M\,O%+12^+M;NFU?Q=-`V42ZD`"VZGNL4:JF>[;R.#7>?`K]EKP!^S/;RQ?`/ M]E?X>>%7G3;<76DSF.>9?1YOLYD<>Q8UZ.=6^+['/_"&:'_X/)/_`(Q4U\=% MX2.&I*T$[MO=OS[>A>%RV<<=+&XB5YM622T2[+JWYGXB?\'.7P?^(?P]_;7\ M'_M/GP_-/XHSCH:^_OA3_P7N_X)W^(/ M@_X>U0_$Z_F\37>G6\+>"M.T&YN-2:[V!3`D:)M#O$.C78'VK3-9O3O_@F]XI_;S_9PTKXJ_!;1Y;CQUX(1[JQ MTATVRZE8R@-+;`'I*I`=5[D,O4BN9_X(-_\`!2/X7>(/V;-._8\^/OB^S\(_ M$/X=,VEKI?B6<6;WMHK'RRGG%RH.,'C]`_[5^+_!_P"$,T/_`,'D MG_QBO)?CG^Q+\%_VE]2&M_'+]C[X<>(M0"[?[3O+AENB/0SQP+(1[%JRIXV$ M\']6K*\4[IJUU_FC>MEE2GF'US#-*35I)WLUWTV:]#YX_P""W_\`P4T^#OPC M_95\2_LX?"/Q]IWB/XB_$/39-!L]&T&Z6[EL[>Y7RII)!$3M8QLR(OWBS@@< M5SG_``;Z_P#!-OQ+^P[\&_$7[2_[1.G#1/%7C&PC`L=0(C;1])BS*1,3]QG; M#N#]T1IG!!KZB^"7["/P'_9SUI/$WP6_8T^&VA:G'_J=3@N&DNHO]R:6!G3\ M"*]`/#\]O/&T#>&HIVD M[R;M=^7DA0RRK6S!8W$M.45:,5>R[N[U;^1^<_\`P7%_X*S?L>:Q^Q9XO_9N M^#/QGTKQ;XJ\710V)@T"?[1#:P"9)))'F4;.B8`!).:]>_X)-?\`!3#]B#Q] M^R=\,/@I8?&_1=&\6Z/X:L=&N_#6M70MKAKN*-8B(]^%DWL,KM))W8ZU]%Z5 M\`_#.A)LT']E7X8V2GJMI:PQC_QVT%+_`,*'\,+K-OXB7]ECX9#4;6=9K6^% MI#YT4@.0ZO\`9-RL#R"#FB6(P;P:HJ#T=[W6]K;6V'#!YA','B93B[I*UGM> M^]]SY>_X.+OV25_:+_8,O?B-H6F>=KWPUO!K-HT:Y?LQZS^U+XKM)/[2\^%O$WPY\/7FG:E:26U_9W&M2-'/#(I5T8>1R"I(/UJE\/?"?B M?X3^"-,^''PY^%'AG1]#T6S2TTO3++695BMH4&%11Y'ZGD]31',:D$[N] M_+L.64499RL=U4;6\]D_N/$/^"B7_!2K]C']G;X+^/?A_P"._CCHDWBJ3P[? M:?%X5T^Z%Q?&YE@=%C>-,^7RX)WXP*_##_@BE^UU\+OV-?V^M$^+GQFU1].\ M-WVEWNE:CJ"1-(+,3A2LC*H)*!D4'`)`.>U?T3:O\"_#VN^(;CQ=KO[+?PTO M=6NY-]SJ=W;Q27$S?WGD:T+,?887"X6='V;?/N[I?=H(]HH\CNE9OKUU/+OVG/#?[-'_!7 MS]BWQI\%/@I\9O#_`(D6[M8I;+4=)OUF_LZ_0^;;-*H^:/+)@A@"5+>]?DG_ M`,$Q/V^OB'_P1+_:#\8_LN?MA_#C6+/P]JM_&^K00VQ,]A!?AW=?"Z.Y3X:?`+P+X=6]97O%T)UM!.RYP7\JV7<1DX)SC- M8'QT_9K\'?M-:;%I7Q^_9A\`^+(K<$6SZSF?]DBIPF/I4:4 MZ%2+E3ETNKI]T7CLIQ&)K0Q=*:C6CI>SLUV:W/GWQ?\`\'"__!/2TT&%OA5X MGU[QQXCORL6D>%=!T&8W=W<-PD7S@!23QWKZ-_9#U3]I+XA?!:;Q;^USXZ13U"S20,Z@]P",UZ^-5^+YY'@O0__``>2?_&* MX\1/"6Y_OOA-J.NW*V&IV\99)=(N]PEM';H+B`,&`)&\PJ>A./VU=7X\\)^)/BCX8NO!/ MQ)^#?A#7](O4V7>EZQ?&YMYA_M));E3^7%>*>$O^"7/[(G@7Q6GC;PU^P9\+ MH=1CE$D4DUS).D;@Y#+'+"T:D'IA>*ZL1C:&.A%UTU.*M=6U7G?K]YQ83+<7 MEE2<<+).G)WL[W3>]K;H_$G_`(*I?MB>&/C?_P`%1K3]J/PWX0U:R\.Z=/H= MQI"ZI;&&?4[*T=76Z6-L%4EVL4SU7:>]?MC\7K/X"?\`!:/_`()[^*?!?PLU MJ].GZ[;!=+OM4TN6U>SU*$K-`Q611D!PH)7((+#-=\W[*/P[G^,=W^T!??LL M^`+SQE>06\4NOW]R9YXT@C$<2Q>9`1#M50/D"]*])CU'XM0H(X_!&@JH'"KK M<@`_\@5IB\SHUJ=)4H.,J:5G?TZ==NYEE^35\/4KNO-2C5;NK-;WZWTW/P4_ MX)F?MV_$C_@B#^T=XQ_9D_:^^&^KVOAS6+N-]7@AMR9K*XCRD=[`#@31.AP= MI^8!2#\N*_2SQ;_P<+_\$[[/P]%-\,O%6O>-/$-\5BTCPKH7A^8W=U<-PD7S M`!22<=37T%\=/V;O"/[3&E1:-\??V9/`/BR&WR+9M:N3+)!GKY6YMET?84:L72Z73;2?16LOO#X#_M)?%GPK\!KKXL M_MLG1_#OB#6=1FOM%\#Z:RFZTJP94%O9RG.99^&9W(`!?'\-7?V5XG^-NN:C M^TEXYO;:ZOKMY+/1=+24.NEV@."-O9F[D]1D]ZW-3^`6DZWK-UXAUCX`>$+J M]O93+=37&LS.7<]3S#@?A5[P/\*+KX:ZK/K7@3X,^&-,N;B+RYI;;79QN7.< M8,)`Y]J\F_2A*,(Q;;MU>[\V?*_P"TWX8C_9H_:*@\4_"O6H8? M-(O[:W@E#&UQKZU^`W[1G@3XX>%+;4M/U>VMM5*!;W29;A1+ M%)WV@G+*>H(]:YZZ_9T\/WNI3ZU>_L^>$9KFZF:6XEFUJ=R[L1:C;_L\^$(KBWE66&6'69TV.IR#\L0[BB4HRBD]RHJ4976QYU^V7'^T M1K?Q1MM8^%WA/5SI_A[39(8M1LX,GS)E(E9!USL.W(';BO-O@_\`%S4-8N;/ M0/$'A+5-=.BOC2?"%D#%;>=G+7-Y(WWV+$D[N_H.*T[3XO\`[73?M*+I-Q/J MPG.M>4^B"-C:B#?@@#&TKMYW]>^:F_:R\'>']4_:L?3?"L&BF>ZTV"34K?4M M1%K`]V2V5+9`W%/+)&IK1*R460W=\R/9+?Q1XS\6@7'QH^/7A[PC8-_S M+OAK5(5N6']V2X8EAZ$(!^%>E_#:W^&.GVGD?#NQW(_W[Q;>5C-_M--(,O\` M7<:\?^&7PN_:#\%Q13^&O@[\,+$X!6Z$\CRD>OF!&)_[ZKU/2)_VD6P-:TWP M;&._V>>Y;^8%8RMT-8L[NBLO2U\9;0=:ETS..1:QR#'_`'TU%0:&I1110`44 M44`%%%%`!1@>E%%`!1110`8`Z"BBB@`HHHH`****`"BBB@`HP.F***`"BBB@ M`HHHH`,#&,4444`%%%%`!1110`4444`%%%%`!@=<4444`%%%%`'R=\?_`(O? MM)>!/CNGPP@\=VUCI>O2J-(U-M)AW112':%+A<_*W!/7O6/X%^$?Q"T&?5/$ M6J>&4\37UG=>7XY\(:PHEEN0>5O+61N2'7D#U5ADC@>U?MD?!V7XG?#)M=T& MWW:[X;E^WZ8R#YG"\O%^(&1[J*[CX>T58RY&Y:G+?"7PKX/OM"A\4?!#QKJ.G6;G$ND7+FXMX7'WHGA MD.Z)@>"%93Q7I-F;T0`:@(_-`^8PYVGW`/(^G/U-8%YX`M;/Q&_C3P@RV&HS M8%^B#$-^H[2J/XAV%7FCV,1\RYS@^E9MW-$K#Z***0PHHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`:R*RE7`((Y![UB^!O#UEX4T EVX\-Z9D6MM?2M;H1_JUD(EV#V!D('L!110!N4444`%%%%`'_V3\_ ` end